Skip to main content
INCY
NASDAQ Life Sciences

Incyte Hits 52-Week High After Q2 Beat and Raised Guidance

Tom Rudovsky · Reported by dpa-AFX
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$119
Mkt Cap
$25.958B
52W Low
$69.695
52W High
$132.6
52W Position info
71% above low
Off High info
10% below high
Rel. Volume info
3.3× avg
Market data snapshot near publication time

INCY sits 71% above its 52-week low of $69.695 on elevated volume (3.3× avg).

Summary

Incyte shares surged over 9% to a 52-week high of $132.58 following Q2 results that beat expectations and a raised full-year outlook. Revenue jumped 38% to $1.67 billion, driven by strong demand across Jakafi, Opzelura, and other key products. The company lifted 2026 revenue guidance to $5.13–$5.26 billion, reflecting up to 21% growth. This follows yesterday's initial report and adds the market's strong reaction, signaling confidence in the broad-based momentum. With ten data readouts expected in H2 2026, the pipeline remains a key focus.

At the time of this announcement, INCY was trading at $119.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $26B. The 52-week trading range was $69.70 to $132.60. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: dpa-AFX.


Price Chart

Share this article

Copied!

INCY - Latest Insights

INCY
Oct 29, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $116.80
Real-time Price: $120.01 info
Change: +$3.21 (+3%) info
Market Cap: $24.461B info
INCY
Oct 29, 2026, 11:07 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $115.20
Real-time Price: $120.01 info
Change: +$4.81 (+4%) info
Market Cap: $24.461B info
INCY
Oct 29, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $117.76
Real-time Price: $120.01 info
Change: +$2.25 (+2%) info
Market Cap: $24.461B info
INCY
Aug 31, 2026, 4:34 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $123.22
Real-time Price: $120.01 info
Change: -$3.21 (-3%) info
Market Cap: $24.461B info
INCY
Jul 29, 2026, 6:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $119.00
Real-time Price: $120.01 info
Change: +$1.01 (+0.85%) info
Market Cap: $24.461B info